- Home
- JANX vs PRCH Comparison
JANX vs PRCH Comparison
Compare JANX & PRCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JANX | PRCH |
|---|---|---|
| Founded | 2017 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 790.3M | 753.7M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | JANX | PRCH |
|---|---|---|
| Price | $13.76 | $7.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $53.60 | $17.11 |
| AVG Volume (30 Days) | 759.1K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.91 |
| EPS | N/A | ★ N/A |
| Revenue | $10,000,000.00 | ★ $482,414,000.00 |
| Revenue This Year | N/A | $3.86 |
| Revenue Next Year | N/A | $16.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.18 |
| 52 Week Low | $12.12 | $4.65 |
| 52 Week High | $35.34 | $19.44 |
Technical Indicators
Market Signals| Indicator | JANX | PRCH |
|---|---|---|
| Relative Strength Index (RSI) | 49.58 | 46.22 |
| Support Level | $13.80 | $6.36 |
| Resistance Level | $14.44 | $8.29 |
| Average True Range (ATR) | 0.51 | 0.41 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 39.09 | 38.46 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.